New Delhi, April 20 (IANS) Namita Thapar, judge on Shark Tank India and Executive Director of Emcure Pharmaceuticals, on Monday hit back at trolls after facing online backlash over her remarks on the health benefits of namaz posted on Instagram in March.Thapar said she and her mother were subjected to abusive comments following her social media post, prompting her to respond strongly and call out what she termed selective outrage.Questioning the criticism, she pointed out that her earlier commen…
Latest Emcure Pharmaceuticals News & Updates
New Delhi, Dec 26 (IANS) From changing the definition to the rise of GLP-1 medications, and the government’s several initiatives, especially Prime Minister Narendra Modi’s clarion call, obesity became the focus of healthcare in India in 2025.The anti-obesity drive, especially the generic drugs, will continue to remain a key focus in 2026.Traditionally, Body Mass Index (BMI) was used to define obesity, but after 15 long years, India revamped its obesity guidelines in 2025 by lowering the thresh…